Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

Journal of the American Academy of Dermatology

Volumn 38, Issue 6 II, 1998, Pages

  Scher, R K ^a   Breneman, D ^a   Rich, P ^a   Savin, R C ^a   Feingold, D S ^a   Konnikov, N ^a   Shupack, J L ^a   Pinnell, S ^a   Levine, N ^a   Lowe, N J ^a   Aly, R ^a   Odom, R B ^a   Greer, D L ^a   Morman, M R ^a   Bucko, A D ^a   Tschen, E H ^a   Elewski, B E ^a   Smith, E B ^a  

^a New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ABDOMINAL PAIN; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; RESPIRATORY TRACT DISEASE; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TRICHOPHYTON RUBRUM;

EID: 0031748868     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70490-6     Document Type: Review

References (34)